This Week in PLOS | GenomeWeb

This Week in PLOS

In PLOS One, researchers from Georgetown University and elsewhere describe a set of frequently mutated and/or copy number altered genes associated with poor breast cancer outcomes. The team profiled ductal carcinoma in situ samples and took advantage of genomic data on infiltrating ductal carcinoma cases from the Cancer Genome Atlas, looking at the prevalence of cases involving loss or low levels of SYK — a gene suspected of contributing to immunity and cancer risk.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

This Week in PLOS

This Week in PLOS

This Week in PLOS

This Week in Cell

This Week in PLOS

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.